1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321
Strong Performer, Getting Expensive
Download real time
1013.85 1.90 (0.19%)
27.53% Gain from 52W Low
2.0M
NSE+BSE Volume

NSE 05 Sep, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Licensing Agreement
Zydus Life's arm enters a licensing agreement with Synthon BV to market Ozanimod capsules in the US See details

Zydus Lifesciences Ltd. quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents